Skip to main content
. 2020 May 23;158:104950. doi: 10.1016/j.phrs.2020.104950

Table 2.

Vital signs and gas exchange parameters at different time-points after study drugs administration in treated patients (n = 5) and compared with matched controls. Data are expressed as means (standard deviation). Within – P(1) - and between - P(2) – group difference is reported. Statistically significant differences are in bold. Resp. rate: respiratory rate; bpm: breaths per minute; ASBP: arterial systolic blood pressure; HR: heart rate. For other abbreviations please see Table 1 and main text.

Group Baseline 24 h 48 h 7 d P (1) P (2)
Vital signs
Resp. rate, bpm Treated 27 (6) 26 (6) 25 (5) 22 (6) 0.049 0.127
Control 28 (5) 27 (5) 25 (5) 25 (6) 0.051
ASBP, mmHg Treated 105 (22) 110 (20) 112 (18) 120 (20) 0.168 0.638
Control 125 (30) 130 (28) 120 (26) 115 (34) 0.237
HR, beats/min Treated 94 (10) 90 (8) 96 (10) 88 (7) 0.069 0.142
Control 96 (12) 94 (15) 90 (11) 92 (14) 0.146
Gas exchange
pH Treated 7.48 (0.04) 7.47 (0.04) 7.44 (0.03) 7.47 (0.07) 0.309 0.959
Control 7.48 (0.05) 7.48 (0.04) 7.46 (0.03) 7.49 (0.01) 0.406
PaO2, mmHg Treated 73 (18.9) 102 (44.7) 106 (34.2) 95 (32.6) 0.693 0.875
Control 97 (37) 90 (19) 98 (22) 78 (16) 0.455
PaCO2, mmHg Treated 39 (4.9) 43 (3.4) 44 (4.2) 41 (4.2) 0.144 0.852
Control 39 (7.2) 43 (7.3) 42 (6.4) 42 (9.0) 0.274
PaO2/FiO2, mmHg Treated 146 (42.4) 198 (56.9) 210 (43.5) 258 (62.3) 0.037 0.207
Control 161 (6.2) 139 (43) 166 (45) 181 (78) 0.283
A-a O2, mmHg Treated 248 (69.6) 216 (54.4) 196 (54.4) 97 (48.0) 0.005 0.047
Control 282 (36) 354 (122) 292 (130) 226 (92) 0.305
SaO2, % Treated 94 (3) 96 (4) 98 (2) 97 (2) 0.220 0.553
Control 96 (4) 98 (2) 98 (1) 96 (4) 0.521
HCO3-, mmol/L Treated 29.9 (3.0) 30 (3.6) 28.8 (2.8) 29.5 (5.7) 0.186 0.939
Control 28.2 (5.2) 29.8 (2.7) 29.4 (3.2) 30.3 (4.8) 0.738
Lactates, mmol/L Treated 1.4 (0.6) 1.4 (0.9) 1.3 (0.8) 1.0 (0.5) 0.487 0.029
Control 1.6 (0.9) 1.3 (0.3) 1.8 (1.1) 2.1 (0.4) 0.439
HHS Vulnerability Disclosure